The Univeristy of Melbourne The Royal Melbourne Hopspital

A joint venture between The University of Melbourne and The Royal Melbourne Hospital

Barbara Scher

Barbara Scher

Barbara Scher

(03) 8344 0770 |

Clinical Research Liason Officer
Immunology, Viral Infectious Diseases, Antimicrobial Resistance, Bacterial and Parasitic Infections
Clinical and health systems research
Doherty Directorate
Lab Group(s):
Lewin Group

Barbara contributes to the development of clinical research activities within the Doherty Institute, and work on projects examining a range of acute and chronic viral as well as bacterial diseases caused by agents including HIV, Hepatitis B, TB, Group A staph and intestinal microbiota. She provides support to Doherty clinical researchers in respect to:

  • Study protocol and PICF development
  • Ethics/governance submissions within the University and across multiple institutions, including hospitals
  • Post approval regulatory documentation support required by ICH GCP
  • Provide monitoring activities
  • Electronic clinical research database design via REDCap
  • Key Achievements
    • Barbara majored in Biochemistry and graduated with a BSc(Hons) MSc from Monash University. After graduating, Barbara went on to work in the field of male infertility at both the Centre for Early Human Development (Queen Victoria Hospital) and Department of Anatomy, Monash University. In 1996, Barbara changed fields and worked as a Clinical Research Coordinator in Oncology and Haematology clinical trials. In 2001, she set up the Oncology/Haematology Clinical Research Unit at Cabrini Health and became the inaugural manager of the unit from 2005 to 2015.

      Currently Barbara is a member of the University of Melbourne Clinical Trials Policy Worrking group as well as a member of the newly formed MACH Infectious Diseases Executive Committee.

    Research Groups
    • Lewin Group

      The focus of the Lewin group is to understand why HIV infection persists on antiretroviral therapy and to develop new strategies to eliminate latency. The lab also researches factors that drive liver disease in HIV-hepatitis B virus co-infection. The lab is also actively involved in COVID in relation to pathogenesis, the use of primary tissue models, and developing therapeutics using gene editing strategies.

      Lab Team

      Lewin Group

      • Director - The Peter Doherty Institute for Infection and Immunity
      • Deputy Head Lewin Lab | Senior Research Fellow
      • Senior Research Fellow
      • Dr Wei Zhao
        Research Fellow
      • Dr Chris Chiu
        Research Fellow
      • Dr Youry Kim
        Research Fellow
      • Dr Stan Kan
        Research Fellow
      • Dr Jill Lau
        Clinical Research Fellow
      • Clinical Research Liason Officer
      • Dr Judy Chang
        Research Systems Administrator
      • Dr Catherine Kennedy
        Research Coordinator
      • Research Coordinator
      • Laboratory Manager
      • Infectious Diseases Physician
      • Research Fellow
      • Carolin Tumpach
        Research Support Officer
      • Rosalyn Cao
        Research Support Officer
      • Danielle Fong
        Research Support Officer
      • Abigail Tan
        Research Support Officer
      • Jared Stern
        PhD Candidate
      • Rachel Pascoe
        PhD Candidate
      • Paula Cevaal
        PhD Candidate
      • Haoming Liu
        PhD Candidate
      • Kiho Tanaka
        PhD Candidate
      • Rory Shepherd
        PhD Candidate
      • Lauren Wallace
        Honours Student
      • Bridget Fisher
        Honours Student
      • Associate Professor Edwina Wright
        Clinical Affiliate
      • Dr James McMahon
        Clinical Affiliate
      • Head, Clinical Virology and HIV Services, Deputy Director Department of Infectious Diseases Austin Health
      • Associate Professor Thomas Rasmussen
        Clinical Affiliate